Literature DB >> 11170040

Diffusion modeling of percutaneous absorption kinetics: 2. Finite vehicle volume and solvent deposited solids.

Y G Anissimov1, M S Roberts.   

Abstract

The diffusion model for percutaneous absorption is developed for the specific case of delivery to the skin being limited by the application of a finite amount of solute. Two cases are considered; in the first, there is an application of a finite donor (vehicle) volume, and in the second, there are solvent-deposited solids and a thin vehicle with a high partition coefficient. In both cases, the potential effect of an interfacial resistance at the stratum corneum surface is also considered. As in the previous paper, which was concerned with the application of a constant donor concentration, clearance limitations due to the viable eqidermis, the in vitro sampling rate, or perfusion rate in vivo are included. Numerical inversion of the Laplace domain solutions was used for simulations of solute flux and cumulative amount absorbed and to model specific examples of percutaneous absorption of solvent-deposited solids. It was concluded that numerical inversions of the Laplace domain solutions for a diffusion model of the percutaneous absorption, using standard scientific software (such as SCIENTIST, MicroMath Scientific software) on modern personal computers, is a practical alternative to computation of infinite series solutions. Limits of the Laplace domain solutions were used to define the moments of the flux-time profiles for finite donor volumes and the slope of the terminal log flux-time profile. The mean transit time could be related to the diffusion time through stratum corneum, viable epidermal, and donor diffusion layer resistances and clearance from the receptor phase. Approximate expressions for the time to reach maximum flux (peak time) and maximum flux were also derived. The model was then validated using reported amount-time and flux-time profiles for finite doses applied to the skin. It was concluded that for very small donor phase volume or for very large stratum corneum-vehicle partitioning coefficients (e.g., for solvent deposited solids), the flux and amount of solute absorbed are affected by receptor conditions to a lesser extent than is obvious for a constant donor constant donor concentrations. Copyright 2001 Wiley-Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 90:504-520, 2001

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11170040     DOI: 10.1002/1520-6017(200104)90:4<504::aid-jps1008>3.0.co;2-h

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  5 in total

1.  Effect of direction (epidermis-to-dermis and dermis-to-epidermis) on the permeation of several chemical compounds through full-thickness skin and stripped skin.

Authors:  Takeshi Oshizaka; Hiroaki Todo; Kenji Sugibayashi
Journal:  Pharm Res       Date:  2012-05-24       Impact factor: 4.200

2.  The transient dermal exposure II: post-exposure absorption and evaporation of volatile compounds.

Authors:  H Frederick Frasch; Annette L Bunge
Journal:  J Pharm Sci       Date:  2015-01-21       Impact factor: 3.534

3.  Assessing topical bioavailability and bioequivalence: a comparison of the in vitro permeation test and the vasoconstrictor assay.

Authors:  Paul A Lehman; Thomas J Franz
Journal:  Pharm Res       Date:  2014-07-09       Impact factor: 4.200

Review 4.  Surging footprints of mathematical modeling for prediction of transdermal permeability.

Authors:  Neha Goyal; Purva Thatai; Bharti Sapra
Journal:  Asian J Pharm Sci       Date:  2017-02-22       Impact factor: 6.598

5.  Analysis of finite dose dermal absorption data: implications for dermal exposure assessment.

Authors:  H Frederick Frasch; G Scott Dotson; Annette L Bunge; Chen-Peng Chen; John W Cherrie; Gerald B Kasting; John C Kissel; Jennifer Sahmel; Sean Semple; Simon Wilkinson
Journal:  J Expo Sci Environ Epidemiol       Date:  2013-05-29       Impact factor: 5.563

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.